Nintedanib Impurity 6 (Intedanib Impurity 6)
BIBF 1202 is the major in-vivo metabolite of BIBF 1120, which is an oral triple angiokinase inhibitor targeting VEGFR, PDGFR, FGFR. It is a related compound of Intedanib, which is an indolinone derivative that inhibits angiokinase and an antitumor agent. It is a novel treatment modality in oncology through blockade of the vascular endothelial growth factor (VEGF) signaling pathway thus inhibition of tumor angiogenesis.
| Supplier | BOC Sciences |
|---|---|
| Product # | B0084-474893 |
| Pricing | Inquire |
| Cas | 894783-71-2 |
| Molecular Weight | 525.60 |
| Molecular Formula | C30H31N5O4 |
| Canonical SMILES | O=C(C1=CC(NC/2=O)=C(C=C1)C2=C(NC3=CC=C(N(C)C(CN4CCN(C)CC4)=O)C=C3)/C5=CC=CC=C5)O |